Skip to content
Screener

LifeStance Health Group LFST Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$363.8MMiss by $14.7M
EPS$0.00Beat by $0.01
Revenue estimate$378.5M
EPS estimate-$0.01

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$431.4M
EPS estimate$0.03

Financials

Q3 2025

Income statement

See full
Revenue$363.8M+16.3%
Operating income$7.4M+15,666%
Net income$1.1M+51.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$203.9M+98.7%
Total debt$473.6M-3.3%
Total equity$1.5B+3.9%
Total assets$2.1B+1.9%

Cash flow

See full
Operating cash flow$27.3M+20.1%
CapEx$10.3M+104%
Free cash flow$17.0M-3.8%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$2.14B-19.5%
Enterprise value$2.41B-20.8%
P/S1.6×-0.6×

Profitability

See full
Operating margin0.4%+0.2pp
Net margin-0.7%-0.3pp
FCF margin8.7%+6.3pp

Returns & leverage

See full
Return on equity-0.6%-0.3pp
Debt / equity0.3×0.0×
Current ratio1.6×+0.3×

FAQ

When did LifeStance Health Group report Q3 2025 earnings?
LifeStance Health Group (LFST) reported Q3 2025 earnings on November 6, 2025 before market open.
What were LifeStance Health Group's Q3 2025 revenue and EPS?
LifeStance Health Group reported revenue of $363.8M and eps of $0.00 for Q3 2025.
Did LifeStance Health Group beat estimates in Q3 2025?
Revenue missed the consensus estimate of $378.5M by $14.7M. EPS beat the consensus estimate of $-0.01 by $0.01.
How did LifeStance Health Group's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 16.3% from $312.7M a year earlier.
Where can I find LifeStance Health Group's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-267443) and the 10-Q periodic report (0001193125-25-269712) directly on SEC EDGAR. The filing index links above go to sec.gov.